JPRN-UMIN000050853已完成Unknown
Oral semaglutide in kidney transplant recipients with metabolic syndrom - Oral semaglutide in kidney transplant recipients
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 3
研究概览
简要总结
Three renal transplant recipients with metabolic syndrome received oral semaglutide for 12 months. All patients lost weight and had no change in eGFR.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Insulin user
研究者
相似试验
招募中
4 期
Semaglutide Treatment for Hyperglycaemia After Renal TransplantationRenal Transplant Complication Primary Non-FunctionDiabetesHyperglycemiaNCT05702931Rigshospitalet, Denmark104
已完成
2 期
Metabolic and Renal Effects of Rosiglitazone in Kidney TransplantKidney TransplantNCT00309309Mario Negri Institute for Pharmacological Research10
Unknown
不适用
Dietary Intervention Trial Targeting Metabolic Syndrome After Kidney TransplantationKidney Transplant ComplicationsNCT04698408University Medical Center Groningen30
招募中
不适用
Metabolomic studies in urine of kidney transplant patientsZ94.0T86.1Kidney transplant statusKidney transplant failure and rejectionDRKS00004343Emmy Noether Programm der Deutschen Forschungsgemeinschaft200
进行中（未招募）
1 期
Semaglutide in the treatment of type 2 diabetes – effects on prevention of weight regain and metabolism after diet induced weight lossEUCTR2020-002712-51-FIKirsi Pietiläinen75